🇺🇸 FDA
Patent

US 10987358

Pharmaceutical compositions comprising meloxicam

granted A61KA61K31/4196A61K31/5415

Quick answer

US patent 10987358 (Pharmaceutical compositions comprising meloxicam) held by AXSOME THERAPEUTICS, INC. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4196, A61K31/5415, A61P, A61P25/06